Dataset opportunity
Microsure — Sensor Telemetry Dataset Opportunity
Moderate sensor telemetry dataset held by Microsure, usable for Predictive Maintenance and Anomaly Detection.
Score
48
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
Global Surgical Robots Market was valued at $8.1 billion in 2024, projected to grow at a CAGR of 17.2% (2025-2034) (source: Global Market Insights Inc.). [6]
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
Sensor Telemetry Dataset
Modality
Time Series
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Industrial AI & maintenance-optimization vendors
Microsure holds a comprehensive Sensor Telemetry Dataset from its robotic microsurgery units, combining Time Series data from `iot_data`, `event_streams`, and `image_collection`. This multi-modal dataset provides high-fidelity kinematic and operational logs, making it exceptionally well-suited for developing and validating Predictive Maintenance algorithms to forecast component wear and prevent system failures in high-stakes surgical environments.
The business value is anchored in the rapidly expanding Global Surgical Robots Market, which was valued at $8.1 billion in 2024 and is projected to grow at a CAGR of 17.2%. [6] While access requires navigating strict medical privacy regulations for surgical video, shared ownership of kinematic data, and integration with hospital-deployed units, the rarity and depth of this data offer a distinct advantage for AI buyers aiming to capture value in this high-growth market. ⚠ Diligence (valuable data, access to negotiate): Surgical video data is highly sensitive and subject to strict medical privacy regulations; Kinematic data ownership may be shared with clinical research partners; Access requires integration with hospital-deployed robotic units · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Microsure owns a proprietary stream of sensor telemetry and operational data from its MUSA surgical robot system. This high-rarity dataset is ideal for industrial AI vendors seeking to build advanced predictive maintenance models that can anticipate component failure and optimize system uptime. In a surgical robotics market projected to grow at over 17% annually, this data offers a unique competitive edge for developing next-generation maintenance solutions.
See dimension details ↓- Dataset Specificity90
dominant 'iot_data', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Predictive Maintenance
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
AI buyer demand is exceptionally high, driven by the urgent need for operational reliability in a market expanding at a 17.2% CAGR. [6]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility20
restricted/unknown
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility14
high difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit75
⚠ review — The company's core business is developing and selling a high-precision robotic system for microsurgery (MUSA), not a business from which data is a by-product. Issues: The company's core product is a MedTech hardware device, the MUSA surgical robot. [3, 5, 8]; The company's business model is the commercialization and sale of this robotic system, not a service or operation that generates data as a side effect. [3, 17]; This company is a product vendor whose core business is selling intelligence/robotics, which is an explicit exclusion criterion.; There are multiple companies with similar names; the target is Microsure in the Netherlands, not Microsure LLC in Georgia, USA, or the microSURE™ disinfectant b
- Deep Qualification80
⚠ needs review — Microsure is a medical device manufacturer selling/leasing its MUSA surgical robot, not a data broker. The generation of sensor telemetry data is a plausible byproduct of its core business. However, this data is highly sensitive (GDPR), and its ownership is complex, likely mixed between Microsure and the client hospitals, presenting significant hurdles for third-party data acquisition. [business model = tooling_vendor]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
IoT / sensor data
This evidence points to granular time-series data from the robot's control interface, capturing joystick movements and tremor-filtering adjustments, which is essential for modeling the performance and wear of critical mechatronic components.
Image collection
This confirms the existence of a complete surgical console and user environment, providing contextual data that can correlate operator session patterns with hardware usage for maintenance optimization.
Event streams
This indicates a continuous stream of system development and research events, offering valuable longitudinal data on system updates and performance changes over time, crucial for building robust and future-proof AI models.
Deal room
Deal Room — Microsure — Sensor Telemetry Dataset Opportunity
Sensor Telemetry Dataset (Time Series, healthcare). Best AI use-case: Predictive Maintenance. Target buyers: Industrial AI & maintenance-optimization vendors. Market: Global Surgical Robots Market was valued at $8.1 billion in 2024, projected to grow at a CAGR of 17.2% (2025-2034) (source: Global Market Insights Inc.). [6]. Rarity: High (proprietary); accessibility: Restricted. Key risk: Owned by the company — GDPR-sensitive (PII review). Recommended deal structure: Data Sharing Agreement. Investment score 48.0/100.
Buyer persona
Industrial AI & maintenance-optimization vendors
The type of company or team most likely to buy or use this dataset — the target on the demand side.Market
Global Surgical Robots Market was valued at $8.1 billion in 2024, projected to grow at a CAGR of 17.2% (2025-2034) (source: Global Market Insights Inc.). [6]
A rough read on demand and price band for this data, from market signals ($ = niche, $$$ = high AI-buyer demand).Risk
Owned by the company — GDPR-sensitive (PII review)
The main legal and compliance constraints on using or transferring this data — PII/GDPR, licensing rights, regulatory limits.Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Coverage
Scanned sources
Deliverable
Premium dataset report
Microsure Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI-enhanced surgical video analytics market = $2.8 billion in 2025, CAGR 18.7% (source: Dataintelo). [9]. Investment score 68.6/100 (confidence 0.49). Recommended action: Data Sharing Agreement.